- Home
- Industry Reports
- Healthcare
- Healthcare IT
- Global Clinical Decision Support Systems Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Clinical decision support system is an essential tool which provides information to the members of the care team which contains clinicians, nurses, patients, administrative staff or other members. The clinical decision support systems market is projected to reach $1,775.0 Million by 2023 from $901.0 Million in 2017, at a CAGR of 11.8%. Drivers that affecting the growth of the market is the growing incidence of medication errors and adoption of cloud computing in healthcare are the factors improves market growth. High investments in infrastructure are hampering the market growth. Technological advancements in healthcare it solutions is an opportunity to increase in market value.
Research Study Objectives:
- Define, estimate, and forecast the Clinical Decision Support Systems market statistics by component, product, type, model, delivery model, application, level of interactivity, setting(Segments), and regions concerning the individual growth drivers, market trends and their contribution toward the Clinical Decision Support Systems market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Clinical Decision Support Systems Market Analysis
- Analysis and conclusions on the future Clinical Decision Support Systems market outlook.
Top-down and bottom-up approaches are used to validate the Clinical Decision Support Systems Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Clinical Decision Support Systems Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Clinical Decision Support Systems market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Clinical Decision Support Systems Market segmentation is as follows:
By Component
- Services
- Software
- Hardware
By Product
- Integrated CDSS
- Standalone CDSS
By Type
- Therapeutic clinical decision support systems
- Diagnostic clinical decision support systems
By Model
- Knowledge-Based CDSS
- Non-Knowledge-Based CDSS
By Delivery Mode
- On-Premise CDSS
- Cloud-Based CDSS
By Application
- Conventional clinical decision support systems
- Advanced clinical decision support systems
By Level of Interactivity
- Active CDSS
- Passive CDSS
By Setting
- Inpatient settings
- Ambulatory care settings
Geographical Analysis:
Clinical Decision Support Systems Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Clinical Decision Support Systems Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Clinical Decision Support Systems Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on year–on–year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Clinical Decision Support Systems market players, such as
- Autonomy Corporation plc.
- EBSCO Industries, Inc.
- Elsevier Clinical Decision Support.
- First Data Bank, Inc.
- GIDEON Informatics, Inc.
- Along with these companies, many other companies are considered in the report while analysing the Global Clinical Decision Support Systems competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing incidence of medication errors
4.1.2. Growing adoption of cloud computing in healthcare
4.1.3. Rapid growth in the geriatric population
4.1.4. Government support and initiatives
4.2. Market Restraints & Challenges
4.2.1. High investments for it infrastructure
4.2.2. Lack of skilled it professionals in the healthcare industry
4.3. Market Opportunities
4.3.1. Technological advancements in healthcare it solutions
4.3.2. Emerging markets for healthcare IT
Chapter 5. Clinical Decision Support Systems Market – By Component
5.1. Introduction
5.2. Services
5.3. Software
5.4. Hardware
Chapter 6. Clinical Decision Support Systems Market, By Product
6.1. Introduction
6.2. Integrated CDSS
6.3. Standalone CDSS
Chapter 7. Clinical Decision Support Systems Market, By Type
7.1. Introduction
7.2. Therapeutic Clinical Decision Support Systems
7.3. Diagnostic Clinical Decision Support Systems
Chapter 8. Clinical Decision Support Systems Market, By Model
8.1. Introduction
8.2. Knowledge-Based CDSS
8.3. Non-Knowledge-Based CDSS
Chapter 9. Clinical Decision Support Systems Market, By Delivery Mode
9.1. Introduction
9.2. On-Premise CDSS
9.3. Cloud-Based CDSS
Chapter 10. Clinical Decision Support Systems Market, By Application
10.1. Introduction
10.2. Conventional Clinical Decision Support Systems
10.3. Advanced Clinical Decision Support Systems
Chapter 11. Clinical Decision Support Systems Market, By Level of Interactivity
11.1. Introduction
11.2. Active CDSS
11.3. Passive CDSS
Chapter 12. Clinical Decision Support Systems Market, By Setting
12.1. Introduction
12.2. Inpatient Settings
12.3. Ambulatory Care Settings
CHAPTER 13. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET – BY
GEOGRAPHY
13.1. Introduction
13.2. North America
13.2.1. U.S.
13.2.2. Canada
13.2.3. Mexico
13.2.4. Costa Rica
13.3. South America
13.3.1. Brazil
13.3.2. Argentina
13.3.3. Chile
13.3.4. Columbia
13.3.5. Others
13.4. Europe
13.4.1. U.K.
13.4.2. Germany
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Netherlands
13.4.8. Switzerland
13.4.9. Poland
13.4.10. Others
13.5. APAC
13.5.1. China
13.5.2. Japan
13.5.3. India
13.5.4. South Korea
13.5.5. Australia & New Zealand
13.5.6. Malaysia
13.5.7. Singapore
13.5.8. Others
13.6. Middle East & Africa
13.6.1. UAE
13.6.2. Saudi Arabia
13.6.3. Iran
13.6.4. Iraq
13.6.5. Qatar
13.6.6. South Africa
13.6.7. Algeria
13.6.8. Morocco
13.6.9. Nigeria
13.6.10. Egypt
13.6.11. Others
CHAPTER 14. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET –
COMPANY PROFILES
14.1. Alere Inc.
14.2. Autonomy Corporation plc
14.3. Cerner Multum, Inc.
14.4. EBSCO Industries, Inc.
14.5. Elsevier Clinical Decision Support
14.6. Evidera/ Archimedes Inc.
14.7. First Data Bank, Inc.
14.8. GIDEON Informatics, Inc.
14.9. IBM Watson
14.10. ICNet International Limited
14.11. Epic Systems Corporation Inc.
14.12. GE Healthcare.
14.13. Optum, Inc.
14.14. Siemens Healthcare
14.15. Philips Healthcare.
CHAPTER 15. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET –
COMPETITIVE LANDSCAPE
15.1. Market Share Analysis
15.2. Strategies adopted by top companies
15.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 16. MARKET INSIGHTS
16.1. Industry Experts Insights
16.2. Analysts Opinions
16.3. Investment Opportunities
CHAPTER 17. APPENDIX
17.1. List of Tables
17.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,509.99 - €7,529.98
- INR: ₹225,095.71 - ₹675,287.14
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,148.05 - £6,444.16
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Clinical decision support system is an essential tool which provides information to the members of the care team which contains clinicians, nurses, patients, administrative staff or other members. The clinical decision support systems market is projected to reach $1,775.0 Million by 2023 from $901.0 Million in 2017, at a CAGR of 11.8%. Drivers that affecting the growth of the market is the growing incidence of medication errors and adoption of cloud computing in healthcare are the factors improves market growth. High investments in infrastructure are hampering the market growth. Technological advancements in healthcare it solutions is an opportunity to increase in market value.
Research Study Objectives:
- Define, estimate, and forecast the Clinical Decision Support Systems market statistics by component, product, type, model, delivery model, application, level of interactivity, setting(Segments), and regions concerning the individual growth drivers, market trends and their contribution toward the Clinical Decision Support Systems market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Clinical Decision Support Systems Market Analysis
- Analysis and conclusions on the future Clinical Decision Support Systems market outlook.
Top-down and bottom-up approaches are used to validate the Clinical Decision Support Systems Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Clinical Decision Support Systems Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Clinical Decision Support Systems market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Clinical Decision Support Systems Market segmentation is as follows:
By Component
- Services
- Software
- Hardware
By Product
- Integrated CDSS
- Standalone CDSS
By Type
- Therapeutic clinical decision support systems
- Diagnostic clinical decision support systems
By Model
- Knowledge-Based CDSS
- Non-Knowledge-Based CDSS
By Delivery Mode
- On-Premise CDSS
- Cloud-Based CDSS
By Application
- Conventional clinical decision support systems
- Advanced clinical decision support systems
By Level of Interactivity
- Active CDSS
- Passive CDSS
By Setting
- Inpatient settings
- Ambulatory care settings
Geographical Analysis:
Clinical Decision Support Systems Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Clinical Decision Support Systems Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Clinical Decision Support Systems Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on year–on–year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Clinical Decision Support Systems market players, such as
- Autonomy Corporation plc.
- EBSCO Industries, Inc.
- Elsevier Clinical Decision Support.
- First Data Bank, Inc.
- GIDEON Informatics, Inc.
- Along with these companies, many other companies are considered in the report while analysing the Global Clinical Decision Support Systems competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing incidence of medication errors
4.1.2. Growing adoption of cloud computing in healthcare
4.1.3. Rapid growth in the geriatric population
4.1.4. Government support and initiatives
4.2. Market Restraints & Challenges
4.2.1. High investments for it infrastructure
4.2.2. Lack of skilled it professionals in the healthcare industry
4.3. Market Opportunities
4.3.1. Technological advancements in healthcare it solutions
4.3.2. Emerging markets for healthcare IT
Chapter 5. Clinical Decision Support Systems Market – By Component
5.1. Introduction
5.2. Services
5.3. Software
5.4. Hardware
Chapter 6. Clinical Decision Support Systems Market, By Product
6.1. Introduction
6.2. Integrated CDSS
6.3. Standalone CDSS
Chapter 7. Clinical Decision Support Systems Market, By Type
7.1. Introduction
7.2. Therapeutic Clinical Decision Support Systems
7.3. Diagnostic Clinical Decision Support Systems
Chapter 8. Clinical Decision Support Systems Market, By Model
8.1. Introduction
8.2. Knowledge-Based CDSS
8.3. Non-Knowledge-Based CDSS
Chapter 9. Clinical Decision Support Systems Market, By Delivery Mode
9.1. Introduction
9.2. On-Premise CDSS
9.3. Cloud-Based CDSS
Chapter 10. Clinical Decision Support Systems Market, By Application
10.1. Introduction
10.2. Conventional Clinical Decision Support Systems
10.3. Advanced Clinical Decision Support Systems
Chapter 11. Clinical Decision Support Systems Market, By Level of Interactivity
11.1. Introduction
11.2. Active CDSS
11.3. Passive CDSS
Chapter 12. Clinical Decision Support Systems Market, By Setting
12.1. Introduction
12.2. Inpatient Settings
12.3. Ambulatory Care Settings
CHAPTER 13. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET – BY
GEOGRAPHY
13.1. Introduction
13.2. North America
13.2.1. U.S.
13.2.2. Canada
13.2.3. Mexico
13.2.4. Costa Rica
13.3. South America
13.3.1. Brazil
13.3.2. Argentina
13.3.3. Chile
13.3.4. Columbia
13.3.5. Others
13.4. Europe
13.4.1. U.K.
13.4.2. Germany
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Netherlands
13.4.8. Switzerland
13.4.9. Poland
13.4.10. Others
13.5. APAC
13.5.1. China
13.5.2. Japan
13.5.3. India
13.5.4. South Korea
13.5.5. Australia & New Zealand
13.5.6. Malaysia
13.5.7. Singapore
13.5.8. Others
13.6. Middle East & Africa
13.6.1. UAE
13.6.2. Saudi Arabia
13.6.3. Iran
13.6.4. Iraq
13.6.5. Qatar
13.6.6. South Africa
13.6.7. Algeria
13.6.8. Morocco
13.6.9. Nigeria
13.6.10. Egypt
13.6.11. Others
CHAPTER 14. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET –
COMPANY PROFILES
14.1. Alere Inc.
14.2. Autonomy Corporation plc
14.3. Cerner Multum, Inc.
14.4. EBSCO Industries, Inc.
14.5. Elsevier Clinical Decision Support
14.6. Evidera/ Archimedes Inc.
14.7. First Data Bank, Inc.
14.8. GIDEON Informatics, Inc.
14.9. IBM Watson
14.10. ICNet International Limited
14.11. Epic Systems Corporation Inc.
14.12. GE Healthcare.
14.13. Optum, Inc.
14.14. Siemens Healthcare
14.15. Philips Healthcare.
CHAPTER 15. GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET –
COMPETITIVE LANDSCAPE
15.1. Market Share Analysis
15.2. Strategies adopted by top companies
15.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 16. MARKET INSIGHTS
16.1. Industry Experts Insights
16.2. Analysts Opinions
16.3. Investment Opportunities
CHAPTER 17. APPENDIX
17.1. List of Tables
17.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.